Isopentyl caffeate as a promising drug for the treatment of leishmaniasis : An in silico and in vivo study
| Autores: | , , , , , , , , , , , , , , |
|---|---|
| Tipo de recurso: | artículo |
| Fecha de publicación: | 2024 |
| País: | España |
| Institución: | Universidad Francisco de Vitoria |
| Repositorio: | DDFV. Repositorio Institucional de la Universidad Francisco de Vitoria |
| Idioma: | inglés |
| OAI Identifier: | oai:ddfv.ufv.es:10641/7839 |
| Acceso en línea: | https://hdl.handle.net/10641/7839 |
| Access Level: | acceso abierto |
| Palabra clave: | ADME Bioavailability In silico Isopentyl caffeate Leishmania Pharmacokinetics Biotechnology SDG 3 - Good Health and Well-being Yes yes |
| id |
ES_33e39ecbd2cd16cf33989a2771d1ce07 |
|---|---|
| oai_identifier_str |
oai:ddfv.ufv.es:10641/7839 |
| network_acronym_str |
ES |
| network_name_str |
España |
| repository_id_str |
|
| spelling |
Isopentyl caffeate as a promising drug for the treatment of leishmaniasis : An in silico and in vivo studyMota, Wanessa S.Oliveira, Simone S.C.Pereira, Matheus M.Souza, Damião P.Castro, MayaraGomes, Pollyanna S.Guedes, Herbert L.M.Souza, Vinícius F.Santos, André L.S.Albuquerque-Junior, Ricardo L.C.Cardoso, Juliana C.Blanco-Llamero, CristinaJain, SonaSouto, Eliana B.Severino, PatríciaADMEBioavailabilityIn silicoIsopentyl caffeateLeishmaniaPharmacokineticsBiotechnologySDG 3 - Good Health and Well-beingYesyesFacultad de Ciencias de la Salud20242024-01-0120242024-01-01journal articlehttp://purl.org/coar/resource_type/c_6501info:eu-repo/semantics/articleapplication/pdfhttps://hdl.handle.net/10641/7839reponame:DDFV. Repositorio Institucional de la Universidad Francisco de Vitoriainstname:Universidad Francisco de VitoriaInglésengopen accesshttp://purl.org/coar/access_right/c_abf2http://creativecommons.org/licenses/by-nc-nd/4.0/info:eu-repo/semantics/openAccessoai:ddfv.ufv.es:10641/78392026-06-11T12:44:57Z |
| dc.title.none.fl_str_mv |
Isopentyl caffeate as a promising drug for the treatment of leishmaniasis : An in silico and in vivo study |
| title |
Isopentyl caffeate as a promising drug for the treatment of leishmaniasis : An in silico and in vivo study |
| spellingShingle |
Isopentyl caffeate as a promising drug for the treatment of leishmaniasis : An in silico and in vivo study Mota, Wanessa S. ADME Bioavailability In silico Isopentyl caffeate Leishmania Pharmacokinetics Biotechnology SDG 3 - Good Health and Well-being Yes yes |
| title_short |
Isopentyl caffeate as a promising drug for the treatment of leishmaniasis : An in silico and in vivo study |
| title_full |
Isopentyl caffeate as a promising drug for the treatment of leishmaniasis : An in silico and in vivo study |
| title_fullStr |
Isopentyl caffeate as a promising drug for the treatment of leishmaniasis : An in silico and in vivo study |
| title_full_unstemmed |
Isopentyl caffeate as a promising drug for the treatment of leishmaniasis : An in silico and in vivo study |
| title_sort |
Isopentyl caffeate as a promising drug for the treatment of leishmaniasis : An in silico and in vivo study |
| dc.creator.none.fl_str_mv |
Mota, Wanessa S. Oliveira, Simone S.C. Pereira, Matheus M. Souza, Damião P. Castro, Mayara Gomes, Pollyanna S. Guedes, Herbert L.M. Souza, Vinícius F. Santos, André L.S. Albuquerque-Junior, Ricardo L.C. Cardoso, Juliana C. Blanco-Llamero, Cristina Jain, Sona Souto, Eliana B. Severino, Patrícia |
| author |
Mota, Wanessa S. |
| author_facet |
Mota, Wanessa S. Oliveira, Simone S.C. Pereira, Matheus M. Souza, Damião P. Castro, Mayara Gomes, Pollyanna S. Guedes, Herbert L.M. Souza, Vinícius F. Santos, André L.S. Albuquerque-Junior, Ricardo L.C. Cardoso, Juliana C. Blanco-Llamero, Cristina Jain, Sona Souto, Eliana B. Severino, Patrícia |
| author_role |
author |
| author2 |
Oliveira, Simone S.C. Pereira, Matheus M. Souza, Damião P. Castro, Mayara Gomes, Pollyanna S. Guedes, Herbert L.M. Souza, Vinícius F. Santos, André L.S. Albuquerque-Junior, Ricardo L.C. Cardoso, Juliana C. Blanco-Llamero, Cristina Jain, Sona Souto, Eliana B. Severino, Patrícia |
| author2_role |
author author author author author author author author author author author author author author |
| dc.contributor.none.fl_str_mv |
Facultad de Ciencias de la Salud |
| dc.subject.none.fl_str_mv |
ADME Bioavailability In silico Isopentyl caffeate Leishmania Pharmacokinetics Biotechnology SDG 3 - Good Health and Well-being Yes yes |
| topic |
ADME Bioavailability In silico Isopentyl caffeate Leishmania Pharmacokinetics Biotechnology SDG 3 - Good Health and Well-being Yes yes |
| publishDate |
2024 |
| dc.date.none.fl_str_mv |
2024 2024-01-01 2024 2024-01-01 |
| dc.type.none.fl_str_mv |
journal article http://purl.org/coar/resource_type/c_6501 |
| dc.type.openaire.fl_str_mv |
info:eu-repo/semantics/article |
| format |
article |
| dc.identifier.none.fl_str_mv |
https://hdl.handle.net/10641/7839 |
| url |
https://hdl.handle.net/10641/7839 |
| dc.language.none.fl_str_mv |
Inglés eng |
| language_invalid_str_mv |
Inglés |
| language |
eng |
| dc.rights.none.fl_str_mv |
open access http://purl.org/coar/access_right/c_abf2 http://creativecommons.org/licenses/by-nc-nd/4.0/ |
| dc.rights.openaire.fl_str_mv |
info:eu-repo/semantics/openAccess |
| rights_invalid_str_mv |
open access http://purl.org/coar/access_right/c_abf2 http://creativecommons.org/licenses/by-nc-nd/4.0/ |
| eu_rights_str_mv |
openAccess |
| dc.format.none.fl_str_mv |
application/pdf |
| dc.source.none.fl_str_mv |
reponame:DDFV. Repositorio Institucional de la Universidad Francisco de Vitoria instname:Universidad Francisco de Vitoria |
| instname_str |
Universidad Francisco de Vitoria |
| reponame_str |
DDFV. Repositorio Institucional de la Universidad Francisco de Vitoria |
| collection |
DDFV. Repositorio Institucional de la Universidad Francisco de Vitoria |
| repository.name.fl_str_mv |
|
| repository.mail.fl_str_mv |
|
| _version_ |
1869405776080011264 |
| score |
15.811543 |